EBElimane Seydi Bousso

Elimane Seydi Bousso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elimane Seydi Bousso has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence, Risk Factors, and Prognostic Impact of Spontaneous Tumor Lysis Syndrome in Aggressive Hematologic Malignancies: Experience From the Clinical Hematology Department, University of Dakar

    by Alioune Badara Diallo, Blaise Félix Faye, Sokhna Aissatou Touré, Elimane Seydi Bousso, Mohamed Keita, Fatma Dieng, Moussa Seck, Saliou Diop

    Spontaneous tumor lysis syndrome (sTLS) is a life‐threatening oncometabolic emergency that remains poorly documented in low‐resource settings. This retrospective cohort study aimed to assess the prevalence, risk factors, and prognostic implications of sTLS in adults with aggressive hematologic malignancies in Dakar, Senegal. Twenty‐six newly diagnosed patients (18 with aggressive non‐Hodgkin lymphomas and 8 with acute leukemias) were included between April 2020 and April 2021. sTLS was defined according to the Cairo–Bishop criteria. Clinical, biological, and survival data were analyzed using univariate tests and Kaplan–Meier estimates. The prevalence of sTLS was 30.8% (8/26). Acute kidney injury was the only factor significantly associated with sTLS ( p = 0.005), while hyperleukocytosis and bulky tumor burden were not correlated. All patients received hyperhydration, and patients at high risk received allopurinol, resulting in normalization of metabolic disturbances within 1 week. Early mortality (≤ 3 months) occurred in 15.4% of patients, and overall mortality reached 38.5%, mainly due to advanced disease. Survival did not differ significantly between patients with and without sTLS (log‐rank = 0.7). In conclusion, sTLS is frequent in Senegalese patients with aggressive hematologic malignancies. Early detection and basic supportive care remain effective for preventing fatal complications in the absence of rasburicase.


  • Open Access

    Management of acute pain in adults with sickle cell disease: the experience of the clinical hematology department of the university of Dakar

    by Ali̇oUne Badara Diallo, Moussa Seck, Mohamed Keita, Sokhna Aissatou Touré, Elimane Seydi Bousso, Baron Ngasia, Blaise Felix Faye, Fatma Dieng, Sali̇oU Diop

    Background/aim: The evolution of sickle cell disease (SCD) is marked by the occurrence of painful episodes linked to the obstruction of micro-vessels by sickle cells, known as vaso-occlusive crises (VOC). The aim of our work was to report the practical aspects of the management of acute pain in adults with SCD. Recommendations based on these practices are also provided.Materials and methods: We conducted a prospective, cross-sectional, descriptive and analytical study over a 4-month period of all sickle cell patients admitted to emergency departments for VOC. The parameters studied were sociodemographic, clinico-biological, therapeutic and evolutionary.Results: 118 cases of VOC were identified, representing a prevalence of 78.14% of sickle cell emergencies. The mean age of the patients was 28.41 years. The SS sickle cell phenotype accounted for 86.61% of cases. Osteoarticular pain was the reason for admission in 88.39% of cases; it was located in the lower limbs in 39.08% of cases and in the spine in 27.1% of cases. Pain intensity was moderate in 6.25% of cases, intense in 31.25% and unbearable in 55.55%. Multimodal analgesia was the most commonly used treatment method, combining levels 1 and 2 (74.31%) and levels 1 and 3 (8.25%). The mean dose of morphine administered was 17.14 mg when morphine alone was prescribed for titration, 13.57 mg when paracetamol and morphine were combined, and 15.83 mg when nefopam and morphine were combined. Clinical outcome was favourable in 68.87% of cases.Conclusion: We noticed a wide variability in the modalities of analgesic treatment of sickle cell VOC. These variations reflect different views on the appropriateness of opioids. This study highlights the efficacy of multimodal analgesia in the management of acute pain in patients with SCD, particularly with regard to morphine sparing. Context-specific recommendations will be needed to harmonize practices.


  • Open Access

    A Case of Rosai-Dorfman Disease Successfully Treated by Corticotherapy

    by Alioune Badara Diallo, Moustapha Ndiaye, Moussa Seck, Mohamed Keita, Elimane Seydi Bousso, Sokhna Aissatou Touré, Blaise Félix Faye, Saliou Diop

    Rosai-Dorfman disease (RDD) is a benign histiocytic proliferation that results in nodal and extranodal involvements. It is a rare disease, with fewer than 1,000 cases reported in the literature, which explains its lack of knowledge by physicians and the lack of codified therapeutic strategies. We report the case of an 8-year-old girl who presented a rapidly progressive cervical lymph node mass; the diagnosis of RDD was made based on histology and immunohistochemistry. The patient was treated with oral corticosteroids at a dose of 1mg/kg/d with a favorable outcome and no recurrence after one year of follow-up. This observation illustrates the clinical presentation and diagnosis of this rare clinicopathological entity. The prognosis and treatment options are also discussed.

  • Open Access

    Prevalence and Predictive Factors of Sickle Cell Emergencies Readmission in the Clinical Hematology Department of Dakar, Senegal

    by Alioune Badara Diallo, Moussa Seck, Sokhna Aissatou Touré, Mohamed Keita, Elimane Seydi Bousso, Blaise Félix Faye, Saliou Diop

    Introduction: Sickle cell emergencies are the most common cause of hospitalization for patients with sickle cell disease (SCD). Hospital readmissions represent a considerable financial burden for healthcare systems and increase patient morbidity and mortality. The aim of this study was to assess the prevalence and predictive factors of sickle cell emergencies readmission.Materials and Methods: We conducted a prospective, cross‐sectional, descriptive, and analytical study over a 4‐month period, including all adult patients admitted for an emergency related to SCD: vaso‐occlusive crisis (VOC), acute chest syndrome (ACS), severe anemia, infections, priapism, and stroke. Readmission was considered when the patient returned to the emergency within a period of Results: We recorded 151 sickle cell emergencies for 112 patients, representing 0.33 emergencies/month/patient. Fifty‐eight cases of readmission were recorded, resulting in a readmission rate of 38.41%. Among these patients, 53 (91.37%) had two admissions, and 5 (8.62%) had three admissions. The median age of the patients was 28.41 years (16–70 years), and the sex ratio was 0.57. The SS sickle cell phenotype was predominant in 97 patients (86.61%). The reasons for readmission were VOC (82.75%), ACS (13.72%), and severe anemia (3.44%). The main factors that predicted readmission were the existence of professional activity, a low fetal hemoglobin (HbF) level, the existence of neutrophilia, lymphocytosis, and/or thrombocytosis (p values of 0.0084, 0.043, and 0.020 respectively).Conclusion: The 30‐day readmission rate after a sickle cell emergency is high in our study. The main factors that predicted readmission were the existence of professional activity, a relatively low level of fetal Hb, the existence of neutrophilia, lymphocytosis, and/or thrombocytosis.


  • Open Access

    P-081: EVALUATION OF THE SEXUALITY OF ADULT HOMOZYGOUS SICKLE CELL PATIENTS WITH A HISTORY OF PRIAPISM IN SENEGAL

    by Seck M., Gaye O., Guèye S., Touré S., Keita M., Diallo A., Bousso E., Faye B., Diop S.

  • Open Access

    O-07: TRANSFUSION PRACTICE, POST-TRANSFUSION COMPLICATIONS AND RISK FACTORS IN SICKLE CELL DISEASE IN SENEGAL

    by Seck M., Senghor A., Loum M., Touré S., Keita M., Diallo A., Bousso E., Faye B., Sall A., Touré A., et al.

  • Open Access

    P-093: PREVALENCE, KNOWLEDGE AND CLINICAL FEATURES OF PRIAPISM IN SICKLE CELL DISEASE IN SENEGAL

    by Seck M., Gaye O., Touré S., Guèye S., Keita M., Diallo A., Bousso E., Faye B., Diop S.

  • Évaluation de la sexualité des drépanocytaires adultes homozygotes ayant des antécédents de priapisme au Sénégal

    by O. Gaye, M. Seck, S.M. Gueye, S.A. Touré, A.I. Diallo, B.F. Faye, N.M. Thiam, E.S. Bousso, M. Jalloh, M. Ndoye, et al.